| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $87.5M | +34.5% |
| SG&A Expense | $49.4M | +8.9% |
| Operating Income | -$136.9M | -24.0% |
| Interest Expense | $2.2M | — |
| Pre-tax Income | -$117.7M | -29.2% |
| Income Tax | $780K | +91.2% |
| Net Income | -$118.5M | -29.5% |
| EPS (Basic) | -$2.32 | -7.4% |
| EPS (Diluted) | -$2.32 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $220.2M | +53.8% |
| Current Assets | $261.3M | +36.3% |
| Total Assets | $276.0M | +39.9% |
| Current Liabilities | $19.6M | +25.7% |
| Long-term Debt | $28.8M | — |
| Total Liabilities | $50.2M | +213.7% |
| Stockholders' Equity | $225.7M | +24.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$97.4M | +7.7% |
| Capital Expenditures | $66K | -88.9% |
| Investing Cash Flow | -$64K | +89.3% |
| Financing Cash Flow | $173.8M | — |
| Free Cash Flow | -$97.4M | +8.1% |
| -7.4% |